Study design and participants
unexplained recurrent pregnancy loss
IRREGULAR MENSTRUAL CYCLE, OBESE, MISCARRIAGES, MISCARRIAGE
A randomized controlled clinical trial was conducted at the Maternity and Child Teaching Hospital in Adiwaniyah province, Iraq. The study was carried out from June 2021 through June 2022. A total of 60 women with a history of unexplained recurrent pregnancy loss in the first trimester, who were not pregnant at the time of the study, were randomly allocated into two groups.The inclusion criteria included: age between 20 and 35 years, BMI<30 kg/m2, two or more recurrent first-trimester miscarriages, and regular menstrual cycle. The exclusion criteria included women with contraindications to either drug being administered, women with known pathological conditions that could cause miscarriage, obese women, and women with irregular menstrual cycles.